Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:59.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior Revision: v3.4.1 along with the government funding/status notice.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice was added indicating possible delays and that the NIH Clinical Center is open, with links to status updates. The site revision was updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:16:20.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new 'Show glossary' option was added. Capitalization edits were made to labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page now shows Revision: v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T05:53:53.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page, which is a minor system update with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:55.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section with the Gyeonggi-do site was added to the study page to indicate recruitment locations. The previous Gyeonggi-do Locations label was removed and the HHS Vulnerability Disclosure link was removed; the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:56:04.000Z thumbnail image

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.